Literature DB >> 25057043

The cost-effectiveness of human papillomavirus vaccine catch-up programs for women.

Harrell W Chesson1, Lauri E Markowitz1.   

Abstract

Entities:  

Keywords:  HPV; cost-effectiveness analysis; human papillomavirus; models; vaccine

Mesh：

Substances：

Year:  2014        PMID： 25057043      PMCID： PMC6745691          DOI： 10.1093/infdis/jiu414

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  A Cost Analysis of the 1-2-3 Pap Intervention.

Authors:  Kristina M Rabarison; Rui Li; Connie L Bish; Robin C Vanderpool; Richard A Crosby; Mehran S Massoudi
Journal:  Front Public Health Serv Syst Res       Date:  2015

2.  Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.

Authors:  Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; Carolyn B Bridges; David K Kim; Tamara Pilishvili; Craig M Hales; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-06       Impact factor: 17.586

3.  Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.

Authors:  Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; David K Kim; Lisa A Grohskopf; Tamara Pilishvili; Tami H Skoff; Noele P Nelson; Rafael Harpaz; Lauri E Markowitz; Alfonso Rodriguez-Lainz; Amy Parker Fiebelkorn
Journal:  MMWR Surveill Summ       Date:  2017-05-05

4.  Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.

Authors:  P Madhivanan; K Krupp; M Coudray; B Colbert; D Ruiz-Perez; H Cui; N Bokulich; G Narasimhan; K Mathee; R L Cook; J Schwebke; D Roe
Journal:  Vaccine       Date:  2021-07-20       Impact factor: 4.169
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.